Standard Chem & Pharm CO., LTD.

Taiwan Stock Exchange 1720.TW

Standard Chem & Pharm CO., LTD. Return on Assets (ROA) for the year ending December 31, 2023: 7.46%

Standard Chem & Pharm CO., LTD. Return on Assets (ROA) is 7.46% for the year ending December 31, 2023, a -29.06% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Standard Chem & Pharm CO., LTD. Return on Assets (ROA) for the year ending December 31, 2022 was 10.52%, a 50.37% change year over year.
Standard Chem & Pharm CO., LTD. Return on Assets (ROA) for the year ending December 31, 2021 was 6.99%, a -5.93% change year over year.
Standard Chem & Pharm CO., LTD. Return on Assets (ROA) for the year ending December 31, 2020 was 7.44%, a 36.83% change year over year.
Standard Chem & Pharm CO., LTD. Return on Assets (ROA) for the year ending December 31, 2019 was 5.43%, a -6.53% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Taiwan Stock Exchange: 1720.TW

Standard Chem & Pharm CO., LTD.

CEO	Mr. Tzu-Ting Fan
IPO Date	Jan. 4, 2000
Location	Taiwan
Headquarters	No. 6-20, Tuku
Employees	1,130
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Standard Chem & Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients. The company was founded in 1967 and is headquartered in Tainan City, Taiwan.

Key trends

Past 5 years